We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
E-stim adds benefit to medication for reflux
Combining transcutaneous electrical acupoint stimulation (TEAS) with proton pump inhibitor (PPI) drugs may be a more effective treatment for laryngopharyngeal reflux disease (LPRD) than medication alone. A Chinese research team randomly assigned 70 patients with reflux symptoms to either receive PPI alone (control group) or TEAS combined with PPI (experimental group) for 12 weeks. Patients in the experimental group received TEAS once a day, five times a week, at Tiantu REN-22, Renying ST-9 and Neiguan P-6. The study found that the experimental group had a significantly greater reduction in reflux symptom scores compared to the control group after 12 weeks of treatment. Both groups showed a significant decrease in throat pain VAS and reflux-associated quality of life scores at four and 12 weeks after treatment, with the TEAS group showing a significant advantage over the control group.
Already subscribed?